Atrandi Biosciences is a series a startup. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Atrandi Biosciences develops innovative microfluidic technologies for single-cell analysis and high-throughput screening in the fields of drug discovery, synthetic biology, and diagnostics.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky